CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
US Bahasa Indonesia
Negara • United States
    Entitas • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    Perdagangan NanoViricides, Inc. - NNVC CFD

    1.0885
    3.54%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.0530
    Biaya inap posisi Long

    Long position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight -0.025457 %
    Charges from borrowed part ($-1.02)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		-0.025457%
    Biaya inap posisi short

    Short position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight 0.003235 %
    Charges from borrowed part ($0.13)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		0.003235%
    Waktu biaya inap 21:00 (UTC)
    Kuantitas min. yang diperdagangkan 1
    Mata uang USD
    Margin 20%
    Bursa efek United States of America
    Komisi perdagangan 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* 1.1284
    Open* 1.1384
    1-Year Change* -41.62%
    Day's Range* 1.0885 - 1.1384
    52 wk Range 1.04-3.88
    Average Volume (10 days) 47.43K
    Average Volume (3 months) 976.46K
    Market Cap 13.42M
    P/E Ratio -100.00K
    Shares Outstanding 11.67M
    Revenue N/A
    EPS -0.59
    Dividend (Yield %) N/A
    Beta 1.10
    Next Earnings Date N/A

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Jun 9, 2023 1.0885 -0.0499 -4.38% 1.1384 1.1384 1.0885
    Jun 8, 2023 1.1284 0.0300 2.73% 1.0984 1.1584 1.0984
    Jun 7, 2023 1.0785 0.0001 0.01% 1.0784 1.1384 1.0784
    Jun 6, 2023 1.1084 -0.0100 -0.89% 1.1184 1.1584 1.0984
    Jun 5, 2023 1.1284 -0.0699 -5.83% 1.1983 1.2383 1.1084
    Jun 2, 2023 1.1583 -0.1199 -9.38% 1.2782 1.2782 1.1583
    Jun 1, 2023 1.2882 0.2797 27.73% 1.0085 1.3881 1.0085
    May 31, 2023 1.0885 0.0100 0.93% 1.0785 1.0985 1.0585
    May 30, 2023 1.0485 -0.0100 -0.94% 1.0585 1.0785 1.0485
    May 26, 2023 1.0585 0.0000 0.00% 1.0585 1.0785 1.0585
    May 25, 2023 1.0785 0.0101 0.95% 1.0684 1.0985 1.0684
    May 24, 2023 1.0884 0.0200 1.87% 1.0684 1.1184 1.0585
    May 23, 2023 1.0684 -0.0300 -2.73% 1.0984 1.1384 1.0684
    May 22, 2023 1.1184 0.0200 1.82% 1.0984 1.1883 1.0984
    May 19, 2023 1.1184 0.0599 5.66% 1.0585 1.1384 1.0585
    May 18, 2023 1.0685 0.0100 0.94% 1.0585 1.0885 1.0585
    May 17, 2023 1.0585 0.0000 0.00% 1.0585 1.1883 1.0485
    May 16, 2023 1.0285 -0.0899 -8.04% 1.1184 1.1184 1.0285
    May 15, 2023 1.0984 -0.0500 -4.35% 1.1484 1.1584 1.0984
    May 12, 2023 1.1284 -0.0399 -3.42% 1.1683 1.2083 1.1184

    NanoViricides, Inc. Events

    Time (UTC) Country Event
    No events scheduled
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 0 0 0 0 0
    Total Operating Expense 8.1136 8.74411 7.99646 8.65968 10.6734
    Selling/General/Admin. Expenses, Total 2.32874 2.62957 3.30094 2.73796 4.49833
    Research & Development 5.78486 6.11454 4.69552 5.92172 4.82684
    Operating Income -8.1136 -8.74411 -7.99646 -8.65968 -10.6734
    Interest Income (Expense), Net Non-Operating 0.00674 -0.07606 -5.30741 0.23524 2.46918
    Other, Net -0.14267 0 -0.35921
    Net Income Before Taxes -8.10686 -8.82219 -13.4465 -8.42444 -8.56346
    Net Income After Taxes -8.10686 -8.82219 -13.4465 -8.42444 -8.56346
    Net Income Before Extra. Items -8.10686 -8.82219 -13.4465 -8.42444 -8.56346
    Net Income -8.10686 -8.82219 -13.4465 -8.42444 -8.56346
    Income Available to Common Excl. Extra. Items -8.10686 -8.82219 -13.4465 -8.42444 -8.56346
    Income Available to Common Incl. Extra. Items -8.10686 -8.82219 -13.4465 -8.42444 -8.56346
    Diluted Net Income -8.10686 -8.82219 -13.4465 -8.42444 -8.56346
    Diluted Weighted Average Shares 11.5347 10.901 5.61673 3.59007 3.24604
    Diluted EPS Excluding Extraordinary Items -0.70282 -0.8093 -2.39402 -2.34659 -2.63812
    Diluted Normalized EPS -0.70282 -0.80912 -2.39402 -2.34659 -2.22277
    Unusual Expense (Income) 0 0 1.34825
    Revenue 0 0 0
    Total Extraordinary Items 0
    Gain (Loss) on Sale of Assets 0 -0.00203
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Total revenue 0 0 0 0 0
    Revenue 0
    Total Operating Expense 1.81074 1.83399 1.62236 1.79278 1.78788
    Selling/General/Admin. Expenses, Total 0.61465 0.66328 0.5097 0.62122 0.5328
    Research & Development 1.19609 1.17071 1.11266 1.17156 1.25507
    Operating Income -1.81074 -1.83399 -1.62236 -1.79278 -1.78788
    Interest Income (Expense), Net Non-Operating 0.10794 0.08886 0.05172 0.01279 -0.00479
    Gain (Loss) on Sale of Assets 0 0
    Net Income Before Taxes -1.7028 -1.74513 -1.57064 -1.78 -1.79266
    Net Income After Taxes -1.7028 -1.74513 -1.57064 -1.78 -1.79266
    Net Income Before Extra. Items -1.7028 -1.74513 -1.57064 -1.78 -1.79266
    Net Income -1.7028 -1.74513 -1.57064 -1.78 -1.79266
    Income Available to Common Excl. Extra. Items -1.7028 -1.74513 -1.57064 -1.78 -1.79266
    Income Available to Common Incl. Extra. Items -1.7028 -1.74513 -1.57064 -1.78 -1.79266
    Diluted Net Income -1.7028 -1.74513 -1.57064 -1.78 -1.79266
    Diluted Weighted Average Shares 11.636 11.6103 11.5924 11.5576 11.5409
    Diluted EPS Excluding Extraordinary Items -0.14634 -0.15031 -0.13549 -0.15401 -0.15533
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.14634 -0.15031 -0.13549 -0.15401 -0.15533
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 14.4164 20.8238 13.9857 2.82542 7.32203
    Cash and Short Term Investments 14.0664 20.5167 13.7086 2.55521 7.08177
    Cash & Equivalents 14.0664 20.5167 13.7086 2.55521 7.08177
    Prepaid Expenses 0.35002 0.3071 0.27706 0.27021 0.24026
    Total Assets 23.4949 30.2623 23.9143 13.4485 18.5462
    Property/Plant/Equipment, Total - Net 8.69419 9.0849 9.54443 10.2273 10.8411
    Property/Plant/Equipment, Total - Gross 14.658 14.3337 14.1008 14.0922 14.0184
    Accumulated Depreciation, Total -5.96382 -5.24877 -4.55638 -3.86493 -3.17729
    Intangibles, Net 0.34185 0.35012 0.35839 0.36666 0.37493
    Other Long Term Assets, Total 0.04244 0.00352 0.02586 0.02919 0.00816
    Total Current Liabilities 0.41284 0.35115 2.15638 2.84815 0.88195
    Accounts Payable 0.27236 0.23156 0.94231 1.13368 0.33081
    Accrued Expenses 0.04569 0.02429 0.06924 0.06887 0.25305
    Notes Payable/Short Term Debt 0.09479 0.09531 1.14483 0 0
    Other Current Liabilities, Total 0 1.64561 0.29809
    Total Liabilities 0.41284 0.35115 2.15638 2.84815 0.88195
    Total Long Term Debt 0 0 0 0 0
    Long Term Debt
    Other Liabilities, Total 0
    Total Equity 23.082 29.9112 21.758 10.6004 17.6643
    Preferred Stock - Non Redeemable, Net 0.00049 0.00037 0.00037 0.00511 0.00453
    Common Stock 0.01159 0.01152 0.00908 0.0769 0.06917
    Additional Paid-In Capital 145.562 144.285 127.312 102.635 101.283
    Retained Earnings (Accumulated Deficit) -122.492 -114.385 -105.563 -92.1166 -83.6921
    Total Liabilities & Shareholders’ Equity 23.4949 30.2623 23.9143 13.4485 18.5462
    Total Common Shares Outstanding 11.5922 11.5152 9.08341 3.84491 3.45859
    Total Preferred Shares Outstanding 0.48458 0.37149 0.3686 5.11404 4.53139
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Total Current Assets 9.93108 11.5529 13.1496 14.4164 15.9467
    Cash and Short Term Investments 9.65096 11.4483 12.918 14.0664 15.5721
    Cash & Equivalents 9.65096 11.4483 12.918 14.0664 15.5721
    Prepaid Expenses 0.28012 0.10455 0.23156 0.35002 0.33718
    Total Assets 18.5768 20.335 22.0823 23.4949 25.1446
    Property/Plant/Equipment, Total - Net 8.2909 8.41785 8.55737 8.69419 8.80472
    Property/Plant/Equipment, Total - Gross 14.8072 14.7479 14.7025 14.658 14.5827
    Accumulated Depreciation, Total -6.51627 -6.33001 -6.14516 -5.96382 -5.77793
    Intangibles, Net 0.33565 0.33771 0.33978 0.34185 0.34392
    Other Long Term Assets, Total 0.01918 0.02651 0.03559 0.04244 0.04922
    Total Current Liabilities 0.34874 0.46459 0.51836 0.41284 0.38673
    Accounts Payable 0.30658 0.41272 0.47081 0.27236 0.19657
    Accrued Expenses 0.04217 0.05188 0.02371 0.04569 0.02525
    Notes Payable/Short Term Debt 0 0 0.02384 0.09479 0.16491
    Total Liabilities 0.34874 0.46459 0.51836 0.41284 0.38673
    Total Long Term Debt 0 0 0 0 0
    Total Equity 18.2281 19.8704 21.564 23.082 24.7579
    Preferred Stock - Non Redeemable, Net 0.0005 0.0005 0.0005 0.00049 0.00048
    Common Stock 0.01167 0.01163 0.01161 0.01159 0.01155
    Additional Paid-In Capital 145.727 145.666 145.615 145.562 145.458
    Retained Earnings (Accumulated Deficit) -127.511 -125.808 -124.063 -122.492 -120.712
    Total Liabilities & Shareholders’ Equity 18.5768 20.335 22.0823 23.4949 25.1446
    Total Common Shares Outstanding 11.6665 11.6346 11.61 11.5922 11.5545
    Total Preferred Shares Outstanding 0.49729 0.49556 0.49517 0.48458 0.4842
    Other Current Assets, Total 0.03741
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -8.10686 -8.82219 -13.4465 -8.42444 -8.56346
    Cash From Operating Activities -5.89125 -8.21384 -6.6656 -6.80277 -7.77587
    Cash From Operating Activities 0.71506 0.69627 0.69145 0.68764 0.67179
    Amortization 0.00827 0.00827 0.00827 0.00827 0.00827
    Non-Cash Items 1.27772 0.44393 5.96155 0.35805 0.07515
    Cash Taxes Paid 0 0 0 0
    Cash Interest Paid 0.00512 0.00486 0 0 0.16667
    Changes in Working Capital 0.21456 -0.54011 0.11966 0.56771 0.03238
    Cash From Investing Activities -0.32435 -0.23876 -0.00864 -0.07379 -0.24182
    Capital Expenditures -0.32435 -0.23876 -0.00864 -0.07379 -0.24182
    Other Investing Cash Flow Items, Total
    Cash From Financing Activities -0.23472 15.2607 17.8276 2.35 0
    Issuance (Retirement) of Stock, Net 0 16.5637 16.677 2.35
    Issuance (Retirement) of Debt, Net -0.23472 -1.30301 1.16284 0 0
    Net Change in Cash -6.45032 6.80808 11.1534 -4.52656 -8.01769
    Financing Cash Flow Items -0.01219
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -5.01858 -3.31578 -1.57064 -8.10686 -6.32687
    Cash From Operating Activities -4.17147 -2.43338 -1.03286 -5.89125 -4.49355
    Cash From Operating Activities 0.55245 0.36619 0.18134 0.71506 0.52917
    Amortization 0.0062 0.00414 0.00207 0.00827 0.0062
    Non-Cash Items 0.16461 0.10412 0.05259 1.27772 1.17355
    Cash Interest Paid 0.00094 0.00094 0.00084 0.00512 0.00349
    Changes in Working Capital 0.12386 0.40795 0.30179 0.21456 0.1244
    Cash From Investing Activities -0.14915 -0.08985 -0.04451 -0.32435 -0.24899
    Capital Expenditures -0.14915 -0.08985 -0.04451 -0.32435 -0.24899
    Cash From Financing Activities -0.09479 -0.09479 -0.07095 -0.23472 -0.20201
    Issuance (Retirement) of Stock, Net 0 0
    Issuance (Retirement) of Debt, Net -0.09479 -0.09479 -0.07095 -0.23472 -0.1646
    Net Change in Cash -4.4154 -2.61801 -1.14832 -6.45032 -4.94454
    Cash Taxes Paid 0
    Financing Cash Flow Items 0 -0.03741
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Theracour Pharma, Inc. Corporation 4.037 470959 0 2022-10-17
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.9295 458416 0 2023-03-31 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 1.3796 160948 0 2023-03-31 LOW
    Compagnie Lombard Odier SCmA Investment Advisor 1.2858 150000 0 2023-03-31 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.954 111293 0 2023-03-31 LOW
    Bridgeway Capital Management, LLC Investment Advisor 0.8061 94039 0 2023-03-31
    Renaissance Technologies LLC Hedge Fund 0.6094 71094 -5879 2023-03-31 HIGH
    Millennium Management LLC Hedge Fund 0.4609 53773 -13573 2023-03-31 HIGH
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.3592 41906 0 2023-03-31 LOW
    Two Sigma Investments, LP Hedge Fund 0.2057 23993 -17110 2023-03-31 HIGH
    Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.1585 18494 0 2023-03-31 LOW
    Wharton Business Group, LLC Investment Advisor 0.1349 15736 0 2023-03-31 LOW
    Citadel Advisors LLC Hedge Fund 0.1303 15205 -73007 2023-03-31 HIGH
    Susquehanna International Group, LLP Investment Advisor 0.1213 14153 14153 2023-03-31 HIGH
    Jawadakar (Makarand) Individual Investor 0.0995 11604 1738 2022-10-17
    Stifel Nicolaus Investment Advisors Investment Advisor 0.0986 11500 11500 2023-03-31 LOW
    Rokita (Theodore) Individual Investor 0.0948 11057 1718 2022-10-17
    Zucker (Brian) Individual Investor 0.0843 9834 1718 2022-10-17
    Vyas (Meeta) Individual Investor 0.063 7352 223 2022-10-17
    Simplex Trading, LLC Research Firm 0.0414 4825 -7814 2023-03-31 HIGH

    Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

    Capital.com Group

    535K+

    Trader

    87K+

    Klien aktif per bulan

    $113M+

    Volume investasi per bulan

    $64M+

    Penarikan tiap bulan

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results
    Laba/Loss
    Industry: Bio Therapeutic Drugs

    1 Controls Drive
    06484

    Income Statement

    • Annual
    • Quarterly

    People also watch

    Oil - Crude

    70.46 Price
    -0.840% 1D Chg, %
    Biaya inap posisi Long -0.0193%
    Biaya inap posisi short -0.0026%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.03

    BTC/USD

    25,588.30 Price
    -2.510% 1D Chg, %
    Biaya inap posisi Long -0.0616%
    Biaya inap posisi short 0.0137%
    Waktu biaya inap 21:00 (UTC)
    Spread 66.00

    Gold

    1,961.15 Price
    -0.240% 1D Chg, %
    Biaya inap posisi Long -0.0187%
    Biaya inap posisi short 0.0105%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.30

    XRP/USD

    0.49 Price
    -7.180% 1D Chg, %
    Biaya inap posisi Long -0.0753%
    Biaya inap posisi short 0.0069%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.00365

    Masih mencari broker yang bisa Anda percayai?

    Bergabung dengan 535.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

    1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda